谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase II Study of a PARP Inhibitor, Talazoparib, in HER2- Metastatic Breast Cancer (MBC) with a Somatic BRCA1/2mutation Identified in a Cell-Free DNA or Tumor Tissue Genotyping Assay.

Neelima Vidula,Senthil Damodaran,Manali A. Bhave,Erica Blouch, Ogadinma Ogbenna,Lisa E. Flaum,Ami N. Shah,Vandana G. Abramson,Massimo Cristofanilli,Joseph A. Sparano,Harry Ostrer,Nora K. Horick,Hope S. Rugo,Aditya Bardia

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用 0|浏览25
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要